Login / Signup

The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.

Wakana MurakamiMitsuhiro TozakiSeigo NakamuraYoshimi IdeMayuko InuzukaYuko HirotaKouzou MurakamiNoritsugu TakahamaYoshimitsu OhgiyaTakehiko Gokan
Published in: Breast cancer (Tokyo, Japan) (2019)
The imaging and histological characteristics of BRCA1/2 mutation carriers were consistent with other countries' studies. MRI-detected lesions were significantly smaller than lesions detected by non-MRI modality. All lesions in BRCA1 mutation carriers could be detected by MRI.
Keyphrases
  • contrast enhanced
  • magnetic resonance imaging
  • diffusion weighted imaging
  • computed tomography
  • magnetic resonance
  • breast cancer risk